🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Naltrexone is a drug which blocks some effects of chemicals called beta-end...
Status
Terminated
Location
Massachusetts General Hosptial
Start Date
2014-05
Trial ID
NCT02137252
Treatments Being Tested
This is a efficacy and safety study evaluating new treatment for subjects w...
Status
Completed
Location
Site Reference ID/Investigator# 19904
Start Date
2009-10
Trial ID
NCT00948909
This randomized, single-dose, placebo- and active-controlled, crossover stu...
Status
Completed
Location
Vince & Associates Clinical Research, Inc
Start Date
2017-03-08
Trial ID
NCT03509285
Treatments Being Tested
This is a randomized study of ambrisentan that will last 16 weeks. The stud...
Status
Terminated
Location
UT Southwestern Medical Center
Start Date
2009-01
Trial ID
NCT00840463
Treatments Being Tested
A total of 18 healthy volunteers will participate in this four-week, within...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00607568
Treatments Being Tested
This is a prospective, double blinded randomized clinical study to evaluate...
Status
Withdrawn
Location
Henry Ford Hospital
Start Date
2010-07
Trial ID
NCT01337349
Treatments Being Tested
The purpose of this study is to learn more about the changes that happen in...
Status
Completed
Location
Emory University Hospital
Start Date
2015-10-09
Trial ID
NCT02513485
Treatments Being Tested
The study team is conducting a study to see if Magnesium-L-Threonate (MgT) ...
Status
Recruiting
Location
University of Miami Hospital
Start Date
2025-04-21
Trial ID
NCT06902285
Treatments Being Tested
The present pilot study is designed to assess the extent to which rasagilin...
Status
Completed
Location
Georgetown University Hospital
Start Date
2012-01
Trial ID
NCT01497652
Treatments Being Tested
An open label, prospective, randomized cross-over phase II study in up to 6...
Status
Completed
Location
Duke University Medical Center
Start Date
2010-06
Trial ID
NCT01077921
Treatments Being Tested